The National Community Pharmacist Association (NCPA) Foundation announced a number of activities held during the NCPA’s 114th Annual Convention and Trade Exposition in mid-October.
The National Community Pharmacist Association (NCPA) Foundation announced a number of activities held during the NCPA's 114th Annual Convention and Trade Exposition in mid-October.
On Oct. 14 and 15, there will be a silent auction of art, pharmacy, and sports memorabilia and travel packages in the Exhibit Hall. The proceeds will support scholarships to pharmacy students, research and programs for independent community pharmacy, community-based health care awareness programs, and disaster relief aid to community pharmacy owners, according to a press statement.
During the convention, community pharmacists can register to participate in the National Community Pharmacy Bone Marrow Drive, which is Nov. 5-10.
During the convention's annual awards and scholarships presentations, a new award, the NARD Ownership Award, will be presented for the first time.
On Oct. 16, there will be a breakfast with entertainment by Mark Riley, Larry Wamble, and Tim Benton.
Click here for more information about the convention and its schedule.
-----------------------------------------------------------
Unlock the Benefits of Centralized Fulfillment for Pharmacists: A Comprehensive Guide
November 6th 2024Streamline your pharmacy operations with centralized fulfillment. Discover how automation and advanced software can improve patient care, reduce operational errors, and create a better work environment for pharmacists. Download our whitepaper to learn how centralized fulfillment can address rising prescription volumes and staffing shortages. Request a consultation today to explore the best solution for your pharmacy.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.